Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Alphamab Oncology, Ascletis, Biontech, Biophytis, Brand Institute, Celltrion, Cstone, Elpiscience, Eubiologics, Everest Medicines, Gilead Sciences, Glaxosmithkline, Glenmark, Immunoprecise Antibodies, Innovent Biologics, Journey Medical, Moderna, Novavax, Pardes, Pfizer, Pharmazz, Qurient, RDIF, Samsung Bioepis, Sanotize R&D, Sinomab, Takeda, Veru.